Telix Pharmaceuticals Limited (TLX) Business Metric Overview - Stocknear

Telix Pharmaceuticals Lim...

NASDAQ: TLX · Real-Time Price · USD
9.26
0.21 (2.32%)
At close: Sep 09, 2025, 9:55 AM

Telix Pharmaceuticals Revenue Breakdown

Period Ending Jun 30, 2019 Jun 30, 2016
Digital Product Sales Revenue 11.74M 776K
Digital Product Sales Revenue Growth +1412.76% n/a
Digital Product Lease And Maintenance Revenue 4M 5M
Digital Product Lease And Maintenance Revenue Growth -19.93% n/a

Operating Expense Breakdown

Period Ending Dec 31, 2024 Jun 30, 2024 Dec 31, 2023 Jun 30, 2023 Dec 31, 2022 Jun 30, 2022 Dec 31, 2021 Jun 30, 2021 Dec 31, 2020 Jun 30, 2020 Dec 31, 2019 Jun 30, 2019 Dec 31, 2018 Jun 30, 2018 Dec 31, 2017 Jun 30, 2017 Jan 31, 2017 Jun 30, 2016 Dec 31, 2015 Jun 30, 2015
Selling, General, and Administrative Revenue 111.82M 64.25M 105.5M 28.93M 21.58M 23.08M 10.59M 6.75M 6.41M 2.88M 5.04M 2.17M 5.14M 4M 2.77M 1.55M 667.82K -647.82K 27K 27K
Selling, General, and Administrative Revenue Growth +74.04% -39.10% +264.73% +34.03% -6.49% +117.87% +56.84% +5.35% +122.60% -42.91% +131.95% -57.69% +28.39% +44.64% +78.64% +131.99% -203.09% -2499.31% 0.00% n/a
Research and Development Revenue 148.85M 45.78M 98.4M 30.45M 33.01M 24.84M 20.46M 13.67M 14.48M 8.61M 13.32M 7.84M 12.24M 6.45M 2.18M 1.6M 744.26K -734.26K 31K 31K
Research and Development Revenue Growth +225.13% -53.47% +223.17% -7.78% +32.89% +21.39% +49.71% -5.59% +68.27% -35.41% +69.93% -35.94% +89.63% +196.71% +35.62% +115.49% -201.36% -2468.60% 0.00% n/a
Sales and Marketing Revenue 48.16M n/a 49.26M 5.6M 27.61M 10.36M 3.5M 2.39M 1.03M 173K 127K 185K 16.57K 55.43K 144.49K 106.88K 53.44K -53.44K n/a n/a
Sales and Marketing Revenue Growth n/a -100.00% +779.07% -79.70% +166.51% +195.66% +46.80% +131.97% +494.80% +36.22% -31.35% +1016.34% -70.10% -61.64% +35.18% +100.00% -200.00% n/a n/a n/a